SCHEMBL24252820

SCHEMBL24252820

CC(=O)OCC1O[C@@H](OC(C)=O)C(NC(=O)CP)[C@@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.67
▸ KMT2A Q03164 1/20 0.55
▸ POLB P06746 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ CYP2D6 P10635 1/20 0.51
▸ THRB P10828 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ TGM2 P21980 1/20 0.48
▸ CA2 P00918 7/20 0.48
▸ CA12 O43570 6/20 0.48
▸ CA1 P00915 6/20 0.48
▸ CA9 Q16790 5/20 0.48
▸ KDM4E B2RXH2 1/20 0.45
▸ TSHR P16473 1/20 0.44
▸ NR3C1 P04150 1/20 0.44
▸ FYN P06241 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24252819 1.00 LMNA (0.67) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL23118203 0.88 LMNA (0.68) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL26979271 0.88 LMNA (0.68) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL23118202 0.88 LMNA (0.68) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL23779761 0.88 LMNA (0.68) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL23777367 0.88 LMNA (0.68) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL29973960 0.87 LMNA (0.67) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL16392798 0.87 LMNA (0.67) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL6950432 0.87 LMNA (0.67) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL29973770 0.87 LMNA (0.67) LMNAKMT2APOLBALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022034177-A1 METHOD FOR TARGETED NUCLEIC ACID CLEAVAGE CAMBRIDGE ENTERPRISE LIMITED (GB) 2022-02-17 — — WO disclosed
Send feedback